eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2007
vol. 2
 
Share:
Share:
abstract:

Review paper
The role of growth factors in pathogenesis of pancreatic cancer. Part III: Vascular endothelial growth factor (VEGF) and insulin-like growth factors (IGFs)

Marek Olakowski

Przegląd Gastroenterologiczny 2007; 2 (4): 181–184
Online publish date: 2007/08/30
View full text Get citation
 
Vascular endothelial growth factor (VEGF) binds with three receptors (VEGFR). VEGFR-1 and 2 are situated mainly in the vascular endothelium whereas VEGFR-3 is located in thelymphatic endothelium. Expression of VEGF is observed in cancer cells in 56-93% of specimens derived from surgically excised pancreatic tumours. There is a correlation between VEGF expression in cancer cells and vascular density in cancer tissue. Some authors have observed a relationship between VEGF expression in cancer cells and grading, staging, liver metastases and survival. The insulin-like growth factor (IGF) family consists of polypeptic ligands IGF-I and IGF-II, 2 types of cell membrane receptors, IGF-IR and IGF-IIR, and 6 binding proteins (IGFBP). Overexpression of IGF and its receptor IGF-IR was observed both in pancreatic cancer cells and in adjacent connective tissue. In pancreatic cancer cells also overexpression of IGF-IIR was demonstrated.
keywords:

pancreatic cancer, vascular endothelial growth factor, insulin-like growth factor

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.